Sonoma Pharmaceuticals Inc (SNOA) Stock Analysis

Sonoma Pharmaceuticals Inc (SNOA) is a publicly traded company in the HEALTHCARE sector. It trades at $1.16, carries a market capitalization of $4.12M. This page summarizes the public market data, fundamentals, and frequently asked questions for SNOA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Sonoma Pharmaceuticals Inc currently has a Neutral sentiment score of -0.14.

About Sonoma Pharmaceuticals Inc

Sonoma Pharmaceuticals, Inc. focuses on the development and production of stabilized hypochlorous acid (HOCl) products tailored for diverse healthcare applications, such as wound care, animal health, eye care, oral care, and dermatological treatments. Headquartered in Woodstock, Georgia, Sonoma leverages innovative technology to enhance patient outcomes across multiple international markets. With a commitment to advancing therapeutic solutions, the company is well-positioned to capitalize on ...

GNG Research Analysis

GNG Research scores Sonoma Pharmaceuticals Inc (SNOA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SNOA.

Frequently Asked Questions

Does SNOA pay dividends?

Sonoma Pharmaceuticals Inc (SNOA) does not currently pay a regular dividend.

What is SNOA's market cap?

Sonoma Pharmaceuticals Inc (SNOA) has a market capitalization of $4.12M with a current stock price of $1.16.